cytosine has been researched along with Hematologic Neoplasms in 23 studies
Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
Excerpt | Relevance | Reference |
---|---|---|
" Nucleoside analogs in development for non-Hodgkin's lymphoma (NHL) include clofarabine, troxacitabine, and bendamustine, a hybrid of an alkylating nitrogen mustard group and a purine-like benzimidazole, with demonstrated activity in NHL." | 4.81 | Hematologic malignancies: new developments and future treatments. ( Cheson, BD, 2002) |
" Adverse drug reactions frequently observed were influenza-like symptoms such as fever (60." | 2.68 | [Bropirimine (U-54461S) early phase II clinical studies--to investigate the efficacy and safety of bropirimine treatment on various malignant tumors (urological, hematologic, and dermal cancers)]. ( Furue, H; Ikeda, S; Machida, T; Masaoka, T, 1997) |
"Gemcitabine is an established agent in the treatment of a number of solid tumours but also has activity in haematological malignancies which might be exploited by the use of extended infusion schedules." | 2.41 | Nucleoside analogues in the treatment of haematological malignancies. ( Johnson, SA, 2001) |
"BK viremia was directly correlated to HC severity (P=0." | 1.40 | High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation. ( Ader, F; Barraco, F; Billaud, G; Chidiac, C; Detrait, M; Ducastelle-Leprêtre, S; Ferry, T; Gilis, L; Labussière-Wallet, H; Michallet, M; Morisset, S; Nicolini, FE; Salles, G; Sobh, M; Tedone, N; Thomas, X, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (4.35) | 18.2507 |
2000's | 6 (26.09) | 29.6817 |
2010's | 15 (65.22) | 24.3611 |
2020's | 1 (4.35) | 2.80 |
Authors | Studies |
---|---|
Hill, JA | 1 |
Nichols, WG | 1 |
Marty, FM | 1 |
Papanicolaou, GA | 1 |
Brundage, TM | 1 |
Lanier, R | 1 |
Zerr, DM | 1 |
Boeckh, MJ | 1 |
Madzo, J | 1 |
Vasanthakumar, A | 1 |
Godley, LA | 2 |
Sakata-Yanagimoto, M | 2 |
Chiba, S | 1 |
Cheng, J | 1 |
Guo, S | 1 |
Chen, S | 2 |
Mastriano, SJ | 1 |
Liu, C | 1 |
D'Alessio, AC | 1 |
Hysolli, E | 1 |
Guo, Y | 1 |
Yao, H | 1 |
Megyola, CM | 1 |
Li, D | 1 |
Liu, J | 1 |
Pan, W | 1 |
Roden, CA | 1 |
Zhou, XL | 1 |
Heydari, K | 1 |
Chen, J | 1 |
Park, IH | 1 |
Ding, Y | 1 |
Zhang, Y | 1 |
Lu, J | 1 |
Gilis, L | 2 |
Morisset, S | 1 |
Billaud, G | 1 |
Ducastelle-Leprêtre, S | 2 |
Labussière-Wallet, H | 2 |
Nicolini, FE | 2 |
Barraco, F | 2 |
Detrait, M | 1 |
Thomas, X | 2 |
Tedone, N | 1 |
Sobh, M | 1 |
Chidiac, C | 1 |
Ferry, T | 1 |
Salles, G | 2 |
Michallet, M | 2 |
Ader, F | 2 |
Sellar, RS | 1 |
Peggs, KS | 1 |
Huang, Y | 1 |
Rao, A | 1 |
Moen, EL | 1 |
Mariani, CJ | 1 |
Zullow, H | 1 |
Jeff-Eke, M | 1 |
Litwin, E | 1 |
Nikitas, JN | 1 |
Meldi, KM | 1 |
Figueroa, ME | 1 |
Pan, F | 2 |
Weeks, O | 2 |
Yang, FC | 2 |
Xu, M | 2 |
Han, JA | 1 |
An, J | 1 |
Ko, M | 1 |
Zhao, Z | 1 |
Chen, L | 1 |
Dawlaty, MM | 1 |
Zhou, Y | 1 |
Cao, Z | 1 |
Shi, H | 1 |
Wang, J | 1 |
Lin, L | 1 |
Yuan, W | 1 |
Qin, Z | 1 |
Ni, H | 1 |
Nimer, SD | 1 |
Jaenisch, R | 1 |
Jin, P | 1 |
Philippe, M | 1 |
Ranchon, F | 1 |
Schwiertz, V | 1 |
Vantard, N | 1 |
Wattel, E | 1 |
Lebras, L | 1 |
Rioufol, C | 1 |
Dahl, C | 1 |
Grønbæk, K | 1 |
Guldberg, P | 1 |
Craddock, C | 1 |
Cheson, BD | 1 |
Schleuning, M | 1 |
Buxbaum-Conradi, H | 1 |
Jäger, G | 1 |
Kolb, HJ | 1 |
Lehmann, U | 1 |
Brakensiek, K | 1 |
Kreipe, H | 1 |
Furue, H | 1 |
Machida, T | 1 |
Masaoka, T | 1 |
Ikeda, S | 1 |
Kiehl, MG | 1 |
Basara, N | 1 |
Johnson, SA | 1 |
Chakrabarti, S | 1 |
Collingham, KE | 1 |
Osman, H | 1 |
Fegan, CD | 1 |
Milligan, DW | 1 |
13 reviews available for cytosine and Hematologic Neoplasms
Article | Year |
---|---|
Perturbations of 5-hydroxymethylcytosine patterning in hematologic malignancies.
Topics: 5-Methylcytosine; Animals; Cytosine; DNA-Binding Proteins; Epigenesis, Genetic; Hematologic Neoplasm | 2013 |
Aberrant cytosine hydroxymethylation in hematologic malignancies.
Topics: Animals; Cell Transformation, Neoplastic; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Prote | 2013 |
Therapeutic strategies for cytomegalovirus infection in haematopoietic transplant recipients: a focused update.
Topics: Acetates; Antiviral Agents; Benzimidazoles; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; H | 2014 |
Connections between TET proteins and aberrant DNA modification in cancer.
Topics: 5-Methylcytosine; Azacitidine; Cytosine; Decitabine; Dioxygenases; DNA Methylation; DNA Modification | 2014 |
[TET2 dysregulation in hematologic malignancies].
Topics: Azacitidine; Cytosine; Decitabine; Dioxygenases; DNA-Binding Proteins; Enzyme Inhibitors; Epigenesis | 2014 |
New themes in the biological functions of 5-methylcytosine and 5-hydroxymethylcytosine.
Topics: 5-Methylcytosine; Animals; Ascorbic Acid; Cytosine; Diet; DNA Methylation; Folic Acid; Hematologic N | 2015 |
Cytosine modifications in myeloid malignancies.
Topics: Animals; Cytosine; DNA Methylation; Epigenomics; Hematologic Neoplasms; Humans; Leukemia, Myeloid; M | 2015 |
The TET2 interactors and their links to hematological malignancies.
Topics: 5-Methylcytosine; Animals; Cytosine; Dioxygenases; DNA-Binding Proteins; Epigenesis, Genetic; Genes, | 2015 |
Functions of TET Proteins in Hematopoietic Transformation.
Topics: 5-Methylcytosine; Animals; Cell Transformation, Neoplastic; Cytosine; Dioxygenases; DNA (Cytosine-5- | 2015 |
Advances in DNA methylation: 5-hydroxymethylcytosine revisited.
Topics: 5-Methylcytosine; Animals; Cell Line; Cytosine; DNA; DNA Methylation; Genome; Hematologic Neoplasms; | 2011 |
Hematologic malignancies: new developments and future treatments.
Topics: Adenine Nucleotides; Alemtuzumab; Alkaloids; Antibodies, Monoclonal; Antibodies, Monoclonal, Humaniz | 2002 |
Role of epigenetic changes in hematological malignancies.
Topics: Animals; Cytosine; DNA Methylation; DNA Modification Methylases; DNA, Neoplasm; Epigenesis, Genetic; | 2004 |
Nucleoside analogues in the treatment of haematological malignancies.
Topics: Antimetabolites, Antineoplastic; Arabinonucleosides; Biological Transport; Cladribine; Clinical Tria | 2001 |
2 trials available for cytosine and Hematologic Neoplasms
Article | Year |
---|---|
[Bropirimine (U-54461S) early phase II clinical studies--to investigate the efficacy and safety of bropirimine treatment on various malignant tumors (urological, hematologic, and dermal cancers)].
Topics: Adult; Aged; Anorexia; Antineoplastic Agents; Cytosine; Drug Administration Schedule; Female; Fever; | 1997 |
Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, | 2001 |
8 other studies available for cytosine and Hematologic Neoplasms
Article | Year |
---|---|
Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Cohort Studies; Cytosine; DNA, Vira | 2020 |
An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis.
Topics: 3' Untranslated Regions; 5-Methylcytosine; Animals; Cytosine; Dioxygenases; DNA-Binding Proteins; Do | 2013 |
High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Female; Graft vs | 2014 |
Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice.
Topics: Animals; B-Lymphocytes; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Down-Regulati | 2015 |
Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Drug Administration Schedule; Fema | 2016 |
Epigenetic manipulation of the immune response: a novel treatment strategy in hematologic malignancies.
Topics: Antigens, Neoplasm; Chromatin; CpG Islands; Cytosine; DNA Methylation; Epigenesis, Genetic; Hematolo | 2011 |
Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants.
Topics: Adenoviridae; Adenovirus Infections, Human; Adolescent; Adult; Aged; Antiviral Agents; Cidofovir; Cy | 2004 |
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytos | 2001 |